about
Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, BrazilHepatitis C among blood donors: cascade of care and predictors of loss to follow-up.IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.Molecular diagnosis of strongyloidiasis in tropical areas: a comparison of conventional and real-time polymerase chain reaction with parasitological methods.Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B.DIAGNOSIS OF Strongyloides stercoralis INFECTION IN IMMUNOCOMPROMISED PATIENTS BY SEROLOGICAL AND MOLECULAR METHODSDistribution of HBV subgenotypes in Ribeirão Preto, Southeastern Brazil: a region with history of intense Italian immigration.Characterization of clinical predictors of naturally occurring NS3/NS4A protease polymorphism in genotype 1 hepatitis C virus mono and HIV co-infected patients.Sequencing of E2 and NS5A regions of HCV genotype 3a in Brazilian patients with chronic hepatitis.Diagnosis of the strongyloid nematode Strongyloides venezuelensis in experimentally infected rats.Interferon lambda and hepatitis C virus core protein polymorphisms associated with liver cancer.Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV.Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.Parasitological and molecular diagnosis in experimental Strongyloides venezuelensis infection.Conventional PCR for molecular diagnosis of human strongyloidiasis.Association of Lactase Persistence Genotypes with High Intake of Dairy Saturated Fat and High Prevalence of Lactase Non-Persistence among the Mexican Population.Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection.Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil.Prevalence of naturally occurring NS5A resistance-associated substitutions in patients infected with hepatitis C virus subtype 1a, 1b, and 3a, co-infected or not with HIV in Brazil.Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects.IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population.Prevalence of naturally occurring amino acid substitutions associated with resistance to hepatitis C virus NS3/NS4A protease inhibitors in São Paulo stateErratum: Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]Lipase and factor V (but not viral load) are prognostic factors for the evolution of severe yellow fever cases.Efficacy of sofosbuvir as treatment for yellow fever: protocol for a randomised controlled trial in Brazil (SOFFA study).Molecular diagnosis of Strongyloides stercoralis among transplant candidatesMolecular and Immnune Diagnosis: Further Testing for Human StrongyloidiasisLiver Transplantation for Fulminant Hepatitis Attributed to Yellow FeverValidation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed populationSubtypes of Blastocystis sp. isolated in fecal samples from transplant candidates in São Paulo, Brazil
P50
Q27478301-E0E0770D-19FC-482B-964C-6343AED55EF2Q33578932-7550E85B-4914-4A69-840E-65F2335544FEQ34214760-4FB02582-7E33-484E-B3A8-B1A4C3F55FADQ35810717-69E67872-691F-4741-8AEE-B31C542EF7D8Q35872542-FA983725-0EFA-4E02-8478-04D5179A6C13Q37234172-917EC7DF-4E1C-42FA-85E2-A6236CFF59A8Q37307890-BD5EDEAB-2E0F-40BB-9A6B-8A11F37D8A10Q38797940-60BEAC4D-0E20-442B-B01F-2717B9DC0934Q39182744-0B3E0445-DF5D-4DA3-AFE8-73EB05304774Q39208854-3508FC79-ECC4-41FC-AFEF-F36B3A6A1543Q39216852-57C65DE2-C76F-4082-B38A-10A93BC2DCE4Q39267671-BAFF1E9F-003F-4036-A645-6D0109BEC300Q39307349-A0087D4C-ADF4-4E2C-84A7-7B6CEDEE0A7BQ39322111-84274D67-C84C-4B1C-AAED-F9249F5BB554Q39343756-93676B89-2793-48DD-A4D5-DEDA4AB204C6Q39469119-8EAB79B2-8D76-46F4-A9DD-12947D085114Q39636892-871A44AC-CE52-438D-9432-6D9FFEA483C9Q41717258-BAB08DFC-C21A-4887-9DCB-0B40C654E995Q43048053-40484BD1-8526-4D83-A283-ABD0C5FB8D15Q45324912-896C6951-7DEC-40A4-8EAD-E32ACE32B4FCQ46255945-55BBDC30-F01C-47F2-B551-A1A37459C6AAQ46957326-960E916C-C5DE-4526-9B96-D03584BBC502Q59357841-CC441D87-BC84-4F94-9755-97507AE86640Q60934867-F4A89E71-3293-41AC-ACD2-05368FA94EF6Q64917021-1D13CA90-983D-4EC1-9675-27F8F8994BCDQ78176907-CE517D47-2A24-4884-B715-6103A51080E5Q88428193-015DE2FF-0F4B-4444-BA88-B554E344846EQ89208321-C9355F71-0B76-4AB2-9ED3-8D49313D757CQ91461330-C9C49672-C235-4AF9-8B2D-761F602E2564Q91760045-56ACF739-8F6B-4DD0-A38D-7FA697140154Q92315161-7AA1F549-2E0F-4C49-AEE4-E1BC0B0BDD00
P50
description
researcher ORCID ID = 0000-0001-8887-5060
@en
name
Fernanda Malta
@ast
Fernanda Malta
@en
Fernanda Malta
@es
Fernanda Malta
@nl
type
label
Fernanda Malta
@ast
Fernanda Malta
@en
Fernanda Malta
@es
Fernanda Malta
@nl
prefLabel
Fernanda Malta
@ast
Fernanda Malta
@en
Fernanda Malta
@es
Fernanda Malta
@nl
P21
P31
P496
0000-0001-8887-5060